- Home
- GAMB vs EBS Comparison
GAMB vs EBS Comparison
Compare GAMB & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAMB
- EBS
- Stock Information
- Founded
- GAMB 2006
- EBS 1998
- Country
- GAMB Jersey
- EBS United States
- Employees
- GAMB N/A
- EBS N/A
- Industry
- GAMB Services-Misc. Amusement & Recreation
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- GAMB Consumer Discretionary
- EBS Health Care
- Exchange
- GAMB Nasdaq
- EBS Nasdaq
- Market Cap
- GAMB N/A
- EBS 393.9M
- IPO Year
- GAMB 2021
- EBS 2006
- Fundamental
- Price
- GAMB $12.59
- EBS $4.86
- Analyst Decision
- GAMB Strong Buy
- EBS Strong Buy
- Analyst Count
- GAMB 7
- EBS 3
- Target Price
- GAMB $16.71
- EBS $14.33
- AVG Volume (30 Days)
- GAMB 448.5K
- EBS 1.4M
- Earning Date
- GAMB 03-20-2025
- EBS 03-03-2025
- Dividend Yield
- GAMB N/A
- EBS N/A
- EPS Growth
- GAMB 78.72
- EBS N/A
- EPS
- GAMB 0.84
- EBS N/A
- Revenue
- GAMB $127,182,000.00
- EBS $1,043,600,000.00
- Revenue This Year
- GAMB $34.55
- EBS $9.43
- Revenue Next Year
- GAMB $14.33
- EBS N/A
- P/E Ratio
- GAMB $15.02
- EBS N/A
- Revenue Growth
- GAMB 17.05
- EBS N/A
- 52 Week Low
- GAMB $7.52
- EBS $1.82
- 52 Week High
- GAMB $17.14
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- GAMB 43.14
- EBS 28.65
- Support Level
- GAMB $12.00
- EBS $4.53
- Resistance Level
- GAMB $14.02
- EBS $5.93
- Average True Range (ATR)
- GAMB 0.59
- EBS 0.41
- MACD
- GAMB 0.10
- EBS 0.03
- Stochastic Oscillator
- GAMB 44.30
- EBS 18.03
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.